John Brehm

Title: John Brehm: Innovator in Protective Antigen Development

Introduction

John Brehm is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of protective antigens. With a total of 3 patents to his name, Brehm's work has had a substantial impact on vaccine development.

Latest Patents

Brehm's latest patents focus on the preparation of protective antigens. One of his key inventions involves a polynucleotide sequence that encodes recombinant Protective Antigen (rPA). This innovation includes expression vectors and host cells that utilize the polynucleotide sequence, along with methods for producing rPA. His work in this area is crucial for advancing vaccine technology.

Career Highlights

Throughout his career, John Brehm has worked with several prominent organizations. He has been associated with Dynport Vaccine Company LLC and the Health Protection Agency. His experience in these companies has allowed him to contribute to important research and development projects in the field of immunology.

Collaborations

Brehm has collaborated with notable colleagues, including Ian McEntee and Philip Vincent. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

John Brehm's contributions to the field of protective antigens demonstrate his commitment to innovation in biotechnology. His patents and collaborations reflect a dedication to advancing vaccine development and improving public health.